Results 201 to 210 of about 37,135 (264)
Some of the next articles are maybe not open access.
Current Pain and Headache Reports, 2004
Migraine is a common, disabling disorder that often requires preventive treatment. The decision to treat migraine preventively generally is based on disability, problems with acute medicines, patient preference, risk of acute medication overuse, special circumstances, and concern that high migraine attack frequency may be a risk factor for chronic ...
William B, Young +2 more
openaire +2 more sources
Migraine is a common, disabling disorder that often requires preventive treatment. The decision to treat migraine preventively generally is based on disability, problems with acute medicines, patient preference, risk of acute medication overuse, special circumstances, and concern that high migraine attack frequency may be a risk factor for chronic ...
William B, Young +2 more
openaire +2 more sources
Annals of Internal Medicine, 1990
Excerpt To the Editor:Two recent letters (1, 2) described the use of anticonvulsants to prevent seizures secondary to high-dose busulfan therapy as a preparative regimen for bone marrow transplanta...
W E, Fitzsimmons, R, Ghalie, H, Kaizer
openaire +2 more sources
Excerpt To the Editor:Two recent letters (1, 2) described the use of anticonvulsants to prevent seizures secondary to high-dose busulfan therapy as a preparative regimen for bone marrow transplanta...
W E, Fitzsimmons, R, Ghalie, H, Kaizer
openaire +2 more sources
Intraction of the Anticonvulsant Ameltolide with standard Anticonvulsants
Epilepsia, 1992Summary: The newly characterized anticonvulsant ameltolide was studied in mice in combination with the standard antiepileptic drugs (AEDs), phenytoin (PHT), carbamazepine (CBZ), and valproate (VPA). In combination with either PHT or CBZ, ameltolide produced dose‐ additive effects in the maximal electroshock (MES) lest and in the horizontal screen (HS)
openaire +2 more sources
Developments in anticonvulsants
1995Epilepsy is one of the oldest of common human ailments and is mentioned in ancient writings such as the Babylonian Code of Hammurabi 2080 BC and in the Hebrew scriptures. Its clinical description was given by Hippocrates in his monograph (ca. 400 BC) on the disease [1]. In earlier times the paroxysmal, uncontrollable behaviour of epileptics was thought
A K, Saxena, M, Saxena
openaire +2 more sources
ARE ANTICONVULSANTS ONCOGENIC?
The Lancet, 1974Abstract The duration of treatment with anti-convulsants—i.e., survival-time checked against national death files—and occurrence of neoplasms, ascertained by means of a cancer registry for 1943-67, were determined in 9136 cases of epilepsy admitted to a hospital from 1933 to 1962.
J, Clemmesen +2 more
openaire +2 more sources